Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Senescence in the Development of Endometrial Cancer

NCT03338985 is registered in ClinicalTrials.gov with CHU de Reims as lead sponsor.

NCT NCT03338985
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03338985 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Senescence in the Development of Endometrial Cancer
Lead sponsor
CHU de Reims
Phase
Not applicable
Overall status
Unknown status
Start date
October 16, 2017
Completion date
April 16, 2020
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial hyperplasia and endometrial cancers